Hypofractionated proton and carbon ion beam radiotherapy for sacrococcygeal chordoma (ISAC): an open label, randomized, stratified, phase II trial

Introduction - Sacrococcygeal chordomas have high recurrence rates and are challenging to treat. - Methods - In this phase II prospective, randomized, stratified trial, the safety and feasibility of hypofractionated ion radiation therapy were investigated. The primary focus was monitored through the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Seidensaal, Katharina (VerfasserIn) , Froehlke, Andreas (VerfasserIn) , Hommertgen, Adriane (VerfasserIn) , Lehner, Burkhard (VerfasserIn) , Geisbüsch, Andreas (VerfasserIn) , Meis, Jan (VerfasserIn) , Liermann, Jakob (VerfasserIn) , Kudak, Andreas (VerfasserIn) , Stein, Katharina (VerfasserIn) , Uhl, Matthias (VerfasserIn) , Tessonnier, Thomas (VerfasserIn) , Mairani, Andrea (VerfasserIn) , Debus, Jürgen (VerfasserIn) , Herfarth, Klaus (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: September 2024
In: Radiotherapy and oncology
Year: 2024, Jahrgang: 198, Pages: 1-7
ISSN:1879-0887
DOI:10.1016/j.radonc.2024.110418
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.radonc.2024.110418
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0167814024006881
Volltext
Verfasserangaben:Katharina Seidensaal, Andreas Froehlke, Adriane Lentz-Hommertgen, Burkhard Lehner, Andreas Geisbuesch, Jan Meis, Jakob Liermann, Andreas Kudak, Katharina Stein, Matthias Uhl, Thomas Tessonnier, Andrea Mairani, Juergen Debus, Klaus Herfarth

MARC

LEADER 00000caa a2200000 c 4500
001 1914147073
003 DE-627
005 20250716221631.0
007 cr uuu---uuuuu
008 250110s2024 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.radonc.2024.110418  |2 doi 
035 |a (DE-627)1914147073 
035 |a (DE-599)KXP1914147073 
035 |a (OCoLC)1528015962 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Seidensaal, Katharina  |d 1987-  |e VerfasserIn  |0 (DE-588)1084643685  |0 (DE-627)848624483  |0 (DE-576)456394869  |4 aut 
245 1 0 |a Hypofractionated proton and carbon ion beam radiotherapy for sacrococcygeal chordoma (ISAC)  |b an open label, randomized, stratified, phase II trial  |c Katharina Seidensaal, Andreas Froehlke, Adriane Lentz-Hommertgen, Burkhard Lehner, Andreas Geisbuesch, Jan Meis, Jakob Liermann, Andreas Kudak, Katharina Stein, Matthias Uhl, Thomas Tessonnier, Andrea Mairani, Juergen Debus, Klaus Herfarth 
264 1 |c September 2024 
300 |b Illustrationen 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 27. Juni 2024, Artikelversion: 3. Juli 2024 
500 |a Gesehen am 10.01.2025 
520 |a Introduction - Sacrococcygeal chordomas have high recurrence rates and are challenging to treat. - Methods - In this phase II prospective, randomized, stratified trial, the safety and feasibility of hypofractionated ion radiation therapy were investigated. The primary focus was monitored through the incidence of Grade 3-5 NCI-CTC-AE toxicity. Secondary endpoints included local progression-free (LPFS) and overall survival (OS). - Results - The study enrolled 82 patients with primary (87 %) and recurrent (13 %) inoperable or incompletely resected sacral chordomas from January 2013 to July 2022, divided equally into proton therapy (Arm A) and carbon ion beam therapy (Arm B) groups, each receiving a total dose of 64 Gy (RBE) in 16 fractions, 5-6 fractions per week. Overall 74 % of patients received no previous surgery and 66 % of tumors were confirmed by a brachyury staining. The mean and median Gross Tumor Volume at the time of treatment (GTV) was 407 ml and 185 ml, respectively. The median follow-up of the surviving patients was 44.7 months, and the 2-year and 4-year OS rates were 96 % and 81 %, respectively. Factors such as smaller GTV and younger age trended towards better OS. The LPFS after 2-year and 4-year was 84 % and 70 %, respectively. Male gender emerged as a significant predictor of LPFS. There was no significant difference between the treatment groups. We observed five grade 4 wound healing disorders (6 %). - Conclusion - The initial response rates were promising; however local control was not sustained. More comparative research on fractionation schemes is essential to refine treatment approaches for inoperable sacral chordoma. 
650 4 |a Carbon ions 
650 4 |a Phase II trial 
650 4 |a Protons 
650 4 |a Radiotherapy 
650 4 |a Sacrococcygeal chordoma 
700 1 |a Froehlke, Andreas  |e VerfasserIn  |4 aut 
700 1 |a Hommertgen, Adriane  |e VerfasserIn  |0 (DE-588)1163409006  |0 (DE-627)1027777600  |0 (DE-576)507971353  |4 aut 
700 1 |a Lehner, Burkhard  |e VerfasserIn  |0 (DE-588)1063147808  |0 (DE-627)810647311  |0 (DE-576)420525297  |4 aut 
700 1 |a Geisbüsch, Andreas  |d 1984-  |e VerfasserIn  |0 (DE-588)1026036178  |0 (DE-627)725953306  |0 (DE-576)37102899X  |4 aut 
700 1 |a Meis, Jan  |d 1992-  |e VerfasserIn  |0 (DE-588)1261856112  |0 (DE-627)180919900X  |4 aut 
700 1 |a Liermann, Jakob  |d 1989-  |e VerfasserIn  |0 (DE-588)1147779287  |0 (DE-627)1007181842  |0 (DE-576)496034170  |4 aut 
700 1 |a Kudak, Andreas  |e VerfasserIn  |0 (DE-588)1223468003  |0 (DE-627)174282773X  |4 aut 
700 1 |a Stein, Katharina  |e VerfasserIn  |0 (DE-588)1353060179  |0 (DE-627)1914147251  |4 aut 
700 1 |a Uhl, Matthias  |d 1979-  |e VerfasserIn  |0 (DE-588)133372561  |0 (DE-627)544031091  |0 (DE-576)299803147  |4 aut 
700 1 |a Tessonnier, Thomas  |e VerfasserIn  |0 (DE-588)1075079195  |0 (DE-627)83292685X  |0 (DE-576)443252270  |4 aut 
700 1 |a Mairani, Andrea  |e VerfasserIn  |0 (DE-588)1116742179  |0 (DE-627)870669281  |0 (DE-576)478592493  |4 aut 
700 1 |a Debus, Jürgen  |d 1964-  |e VerfasserIn  |0 (DE-588)1022671421  |0 (DE-627)717025780  |0 (DE-576)365774944  |4 aut 
700 1 |a Herfarth, Klaus  |e VerfasserIn  |0 (DE-588)1032757582  |0 (DE-627)739273116  |0 (DE-576)171352289  |4 aut 
773 0 8 |i Enthalten in  |t Radiotherapy and oncology  |d Amsterdam [u.a.] : Elsevier Science, 1983  |g 198(2024) vom: Sept., Artikel-ID 110418, Seite 1-7  |h Online-Ressource  |w (DE-627)306710110  |w (DE-600)1500707-8  |w (DE-576)082435731  |x 1879-0887  |7 nnas  |a Hypofractionated proton and carbon ion beam radiotherapy for sacrococcygeal chordoma (ISAC) an open label, randomized, stratified, phase II trial 
773 1 8 |g volume:198  |g year:2024  |g month:09  |g elocationid:110418  |g pages:1-7  |g extent:7  |a Hypofractionated proton and carbon ion beam radiotherapy for sacrococcygeal chordoma (ISAC) an open label, randomized, stratified, phase II trial 
856 4 0 |u https://doi.org/10.1016/j.radonc.2024.110418  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0167814024006881  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250110 
993 |a Article 
994 |a 2024 
998 |g 1032757582  |a Herfarth, Klaus  |m 1032757582:Herfarth, Klaus  |d 910000  |d 911400  |d 50000  |e 910000PH1032757582  |e 911400PH1032757582  |e 50000PH1032757582  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 14  |y j 
998 |g 1022671421  |a Debus, Jürgen  |m 1022671421:Debus, Jürgen  |d 910000  |d 911400  |e 910000PD1022671421  |e 911400PD1022671421  |k 0/910000/  |k 1/910000/911400/  |p 13 
998 |g 1116742179  |a Mairani, Andrea  |m 1116742179:Mairani, Andrea  |d 50000  |e 50000PM1116742179  |k 0/50000/  |p 12 
998 |g 133372561  |a Uhl, Matthias  |m 133372561:Uhl, Matthias  |d 50000  |e 50000PU133372561  |k 0/50000/  |p 10 
998 |g 1353060179  |a Stein, Katharina  |m 1353060179:Stein, Katharina  |d 910000  |d 911400  |e 910000PS1353060179  |e 911400PS1353060179  |k 0/910000/  |k 1/910000/911400/  |p 9 
998 |g 1223468003  |a Kudak, Andreas  |m 1223468003:Kudak, Andreas  |d 910000  |d 911400  |e 910000PK1223468003  |e 911400PK1223468003  |k 0/910000/  |k 1/910000/911400/  |p 8 
998 |g 1147779287  |a Liermann, Jakob  |m 1147779287:Liermann, Jakob  |d 910000  |d 911400  |d 50000  |e 910000PL1147779287  |e 911400PL1147779287  |e 50000PL1147779287  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 7 
998 |g 1261856112  |a Meis, Jan  |m 1261856112:Meis, Jan  |d 910000  |d 911800  |e 910000PM1261856112  |e 911800PM1261856112  |k 0/910000/  |k 1/910000/911800/  |p 6 
998 |g 1026036178  |a Geisbüsch, Andreas  |m 1026036178:Geisbüsch, Andreas  |d 910000  |d 911400  |e 910000PG1026036178  |e 911400PG1026036178  |k 0/910000/  |k 1/910000/911400/  |p 5 
998 |g 1063147808  |a Lehner, Burkhard  |m 1063147808:Lehner, Burkhard  |d 910000  |d 911400  |e 910000PL1063147808  |e 911400PL1063147808  |k 0/910000/  |k 1/910000/911400/  |p 4 
998 |g 1163409006  |a Hommertgen, Adriane  |m 1163409006:Hommertgen, Adriane  |d 910000  |d 911400  |e 910000PH1163409006  |e 911400PH1163409006  |k 0/910000/  |k 1/910000/911400/  |p 3 
998 |g 1084643685  |a Seidensaal, Katharina  |m 1084643685:Seidensaal, Katharina  |d 910000  |d 911400  |e 910000PS1084643685  |e 911400PS1084643685  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1914147073  |e 464949107X 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1914147073"],"doi":["10.1016/j.radonc.2024.110418"]},"name":{"displayForm":["Katharina Seidensaal, Andreas Froehlke, Adriane Lentz-Hommertgen, Burkhard Lehner, Andreas Geisbuesch, Jan Meis, Jakob Liermann, Andreas Kudak, Katharina Stein, Matthias Uhl, Thomas Tessonnier, Andrea Mairani, Juergen Debus, Klaus Herfarth"]},"physDesc":[{"extent":"7 S.","noteIll":"Illustrationen"}],"recId":"1914147073","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Online verfügbar: 27. Juni 2024, Artikelversion: 3. Juli 2024","Gesehen am 10.01.2025"],"title":[{"title_sort":"Hypofractionated proton and carbon ion beam radiotherapy for sacrococcygeal chordoma (ISAC)","title":"Hypofractionated proton and carbon ion beam radiotherapy for sacrococcygeal chordoma (ISAC)","subtitle":"an open label, randomized, stratified, phase II trial"}],"origin":[{"dateIssuedDisp":"September 2024","dateIssuedKey":"2024"}],"relHost":[{"disp":"Hypofractionated proton and carbon ion beam radiotherapy for sacrococcygeal chordoma (ISAC) an open label, randomized, stratified, phase II trialRadiotherapy and oncology","physDesc":[{"extent":"Online-Ressource"}],"recId":"306710110","note":["Gesehen am 30.05.15","Ungezählte Beil.: Supplement"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title":"Radiotherapy and oncology","title_sort":"Radiotherapy and oncology","subtitle":"journal of the European Society for Therapeutic Radiology and Oncology"}],"origin":[{"publisher":"Elsevier Science","publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1983","dateIssuedDisp":"1983-"}],"part":{"text":"198(2024) vom: Sept., Artikel-ID 110418, Seite 1-7","volume":"198","extent":"7","pages":"1-7","year":"2024"},"id":{"zdb":["1500707-8"],"eki":["306710110"],"issn":["1879-0887"]},"titleAlt":[{"title":"The green journal"}],"pubHistory":["1.1983 -"]}],"person":[{"role":"aut","given":"Katharina","family":"Seidensaal","display":"Seidensaal, Katharina"},{"display":"Froehlke, Andreas","given":"Andreas","role":"aut","family":"Froehlke"},{"display":"Hommertgen, Adriane","given":"Adriane","role":"aut","family":"Hommertgen"},{"display":"Lehner, Burkhard","role":"aut","given":"Burkhard","family":"Lehner"},{"display":"Geisbüsch, Andreas","family":"Geisbüsch","given":"Andreas","role":"aut"},{"display":"Meis, Jan","given":"Jan","role":"aut","family":"Meis"},{"display":"Liermann, Jakob","given":"Jakob","role":"aut","family":"Liermann"},{"given":"Andreas","role":"aut","family":"Kudak","display":"Kudak, Andreas"},{"display":"Stein, Katharina","given":"Katharina","role":"aut","family":"Stein"},{"family":"Uhl","given":"Matthias","role":"aut","display":"Uhl, Matthias"},{"display":"Tessonnier, Thomas","family":"Tessonnier","role":"aut","given":"Thomas"},{"display":"Mairani, Andrea","family":"Mairani","role":"aut","given":"Andrea"},{"family":"Debus","given":"Jürgen","role":"aut","display":"Debus, Jürgen"},{"family":"Herfarth","given":"Klaus","role":"aut","display":"Herfarth, Klaus"}]} 
SRT |a SEIDENSAALHYPOFRACTI2024